A new study from the University of British Columbia (UBC) has found that high insulin levels—commonly seen in people with ...

The Revell family hoped a gene therapy could buy time for their sons, who have a rare and fatal disease. After two patients died, the drug’s manufacturer halted dosing under pressure from the FDA.

Jaina Patel was in her early 30s when a bout of bronchitis led to hear losing weight, her job and eventually her sense of ...

VCU Massey Comprehensive Cancer Center is the first site in the United States to be activated in a global Phase 2a clinical ...

Experts are calling for tailored strategies to enhance the diagnosis, treatment, and monitoring of older people with multiple ...

There is an urgent need for more inclusive and community-focused cancer clinical trials, according to Kimberly (Cary) ...

Raleigh-based Focal Medical, an oncology device company that received early funding from the North Carolina Biotechnology Center, has been acquired by a Florida biopharmaceutical company. Financial ...

Unpredictable FDA and funding woes delay crucial drug approvals, depriving thousands of patients access to vital treatments ...

The trial will test several treatment approaches in the maintenance setting for extensive stage small cell lung cancer.

SAP-001 is an investigational oral agent designed to reduce serum uric acid levels by targeting a distinct renal urate reabsorption transporter.

New Jersey-based drugmaker Bristol Myers Squibb this month dedicated its first production facility in Indiana, a former north ...

As life-extending technologies and aging interventions proliferate, questions surround who will be granted access to a longer ...